Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly ...

In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with chronic rhinitis who had ...

GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced three-month data from ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients with allergic rhinitis (AR), misdiagnosis ...

Neurent Medical today announced positive findings from a randomized controlled trial evaluating its Neuromark system.

The Cigna Group CI recently announced that it will start covering RhinAer, a minimally invasive solution for chronic rhinitis, starting Sept. 15, 2025. This move highlights the increasing confidence ...

GALWAY, Ireland--(BUSINESS WIRE)--Neurent Medical, a company pioneering innovative treatments for chronic inflammatory sino-nasal diseases, today announced it has closed a $25 million Series B ...

Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other allergic conditions have improved the quality of care for seasonal allergies ...

The FDA has approved azelastine HCI and fluticasone propionate nasal spray (Dymista, Meda) to treat seasonal allergic rhinitis. The approval comes after several clinical studies involving more than ...

The "Allergic Rhinitis Market- A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global ...